Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus

Genes & Immunity volume 16, pages 15–23 (2015)Cite this article

Subjects

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by inflammation of multiple organ systems and dysregulated interferon responses. SLE is both genetically and phenotypically heterogeneous, greatly reducing the power of case-control studies in SLE. Elevated circulating interferon-alpha (IFN-α) is a stable, heritable trait in SLE, which has been implicated in primary disease pathogenesis. About 40–50% of patients have high IFN-α, and high levels correspond with clinical differences. To study genetic heterogeneity in SLE, we performed a case−case study comparing patients with high vs low IFN-α in over 1550 SLE cases, including genome-wide association study and replication cohorts. In meta-analysis, the top associations in European ancestry were protein kinase, cyclic GMP-dependent, type I (PRKG1) rs7897633 (PMeta=2.75 × 10−8) and purine nucleoside phosphorylase (PNP) rs1049564 (PMeta=1.24 × 10−7). We also found evidence for cross-ancestral background associations with the ankyrin repeat domain 44 (ANKRD44) and pleckstrin homology domain containing, family F member 2 gene (PLEKHF2) loci. These loci have not been previously identified in case-control SLE genetic studies. Bioinformatic analyses implicated these loci functionally in dendritic cells and natural killer cells, both of which are involved in IFN-α production in SLE. As case-control studies of heterogeneous diseases reach a limit of feasibility with respect to subject number and detectable effect size, the study of informative pathogenic sub-phenotypes becomes an attractive strategy for genetic discovery in complex disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Harley JB, Kelly JA, Kaufman KM . Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol 2006; 28: 119–130.

    Article  CAS  PubMed  Google Scholar 

  2. Ko K, Koldobskaya Y, Rosenzweig E, Niewold TB . Activation of the interferon pathway is dependent upon autoantibodies in African-American SLE patients, but not in European-American SLE patients. Front Immunol 2013; 4: 309.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Sanchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, Langefeld CD et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis Rheum 2011; 63: 3493–3501.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ko K, Franek BS, Marion M, Kaufman KM, Langefeld CD, Harley JB et al. Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. J Rheumatol 2012; 39: 1238–1240.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK . High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007; 8: 492–502.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006; 38: 550–555.

    Article  CAS  PubMed  Google Scholar 

  7. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008; 40: 204–210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007; 357: 977–986.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009; 41: 1228–1233.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Rullo OJ, Tsao BP . Recent insights into the genetic basis of systemic lupus erythematosus. Ann Rheum Dis 2013; 72 (Suppl 2): ii56–ii61.

    Article  CAS  PubMed  Google Scholar 

  11. Ghodke-Puranik Y, Niewold TB . Genetics of the type I interferon pathway in systemic lupus erythematosus. Int J Clin Rheumatol 2013; 8: 657–669.

    Article  CAS  Google Scholar 

  12. Kim K, Brown EE, Choi CB, Alarcon-Riquelme ME, Kelly JA, Glenn SB et al. Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Ann Rheum Dis 2012; 71: 1809–1814.

    Article  CAS  PubMed  Google Scholar 

  13. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J . Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001; 294: 1540–1543.

    Article  CAS  PubMed  Google Scholar 

  14. Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL . Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med 1979; 301: 5–8.

    Article  CAS  PubMed  Google Scholar 

  15. Weckerle CE, Franek BS, Kelly JA, Kumabe M, Mikolaitis RA, Green SL et al. Network analysis of associations between serum interferon-alpha activity, autoantibodies, and clinical features in systemic lupus erythematosus. Arthritis Rheum 2011; 63: 1044–1053.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Petri M, Singh S, Tesfasyone H, Dedrick R, Fry K, Lal P et al. Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus 2009; 18: 980–989.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Niewold TB, Clark DN, Salloum R, Poole BD . Interferon alpha in systemic lupus erythematosus. J Biomed Biotechnol 2010; 2010: 948364.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Niewold TB . Interferon alpha-induced lupus: proof of principle. J Clin Rheumatol 2008; 14: 131–132.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Niewold TB, Swedler WI . Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 2005; 24: 178–181.

    Article  PubMed  Google Scholar 

  20. Kariuki SN, Kirou KA, MacDermott EJ, Barillas-Arias L, Crow MK, Niewold TB . Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol 2009; 182: 34–38.

    Article  CAS  PubMed  Google Scholar 

  21. Niewold TB, Kelly JA, Flesch MH, Espinoza LR, Harley JB, Crow MK . Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 2008; 58: 2481–2487.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, Badaracco M et al. Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-alpha and serologic autoimmunity in lupus patients. J Immunol 2011; 187: 1298–1303.

    Article  CAS  PubMed  Google Scholar 

  23. Agik S, Franek BS, Kumar AA, Kumabe M, Utset TO, Mikolaitis RA et al. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes. J Rheumatol 2012; 39: 73–78.

    Article  CAS  PubMed  Google Scholar 

  24. Eliopoulos E, Zervou MI, Andreou A, Dimopoulou K, Cosmidis N, Voloudakis G et al. Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetically homogeneous population of Crete. Lupus 2011; 20: 501–506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK . Augmented interferon-alpha pathway activation in patients with Sjogren's syndrome treated with etanercept. Arthritis Rheum 2007; 56: 3995–4004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Niewold TB, Wu SC, Smith M, Morgan GA, Pachman LM . Familial aggregation of autoimmune disease in juvenile dermatomyositis. Pediatrics 2011; 127: e1239–e1246.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Maiti AK, Kim-Howard X, Motghare P, Pradhan V, Chua KH, Sun C et al. Combined protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM. Hum Mol Genet 2014; 23: 4161–4176.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kariuki SN, Franek BS, Kumar AA, Arrington J, Mikolaitis RA, Utset TO et al. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res Ther 2010; 12: R151.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Koldobskaya Y, Ko K, Kumar AA, Agik S, Arrington J, Kariuki SN et al. Gene-expression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus. Clin Dev Immunol 2012; 2012: 682018.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL . Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001; 159: 237–243.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Hagberg N, Berggren O, Leonard D, Weber G, Bryceson YT, Alm GV et al. IFN-alpha production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1beta and LFA-1. J Immunol 2011; 186: 5085–5094.

    Article  CAS  PubMed  Google Scholar 

  32. Rullo OJ, Woo JM, Wu H, Hoftman AD, Maranian P, Brahn BA et al. Association of IRF5 polymorphisms with activation of the interferon alpha pathway. Ann Rheum Dis 2010; 69: 611–617.

    Article  CAS  PubMed  Google Scholar 

  33. Orstavik S, Natarajan V, Tasken K, Jahnsen T, Sandberg M . Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1). Genomics 1997; 42: 311–318.

    Article  CAS  PubMed  Google Scholar 

  34. Snyder FF, Jenuth JP, Mably ER, Mangat RK . Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse. Proc Natl Acad Sci USA 1997; 94: 2522–2527.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Toro A, Grunebaum E . TAT-mediated intracellular delivery of purine nucleoside phosphorylase corrects its deficiency in mice. J Clin Invest 2006; 116: 2717–2726.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Lipsky PE . Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001; 2: 764–766.

    Article  CAS  PubMed  Google Scholar 

  37. Sasaki Y, Iseki M, Yamaguchi S, Kurosawa Y, Yamamoto T, Moriwaki Y et al. Direct evidence of autosomal recessive inheritance of Arg24 to termination codon in purine nucleoside phosphorylase gene in a family with a severe combined immunodeficiency patient. Hum Genet 1998; 103: 81–85.

    Article  CAS  PubMed  Google Scholar 

  38. Markert ML . Purine nucleoside phosphorylase deficiency. Immunodefic Rev 1991; 3: 45–81.

    CAS  PubMed  Google Scholar 

  39. Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007; 39: 1065–1067.

    Article  CAS  PubMed  Google Scholar 

  40. Al-Mayouf SM, Sunker A, Abdwani R, Abrawi SA, Almurshedi F, Alhashmi N et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet 2011; 43: 1186–1188.

    Article  CAS  PubMed  Google Scholar 

  41. Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 2011; 12: 270–279.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Lin WJ, Yang CY, Lin YC, Tsai MC, Yang CW, Tung CY et al. Phafin2 modulates the structure and function of endosomes by a Rab5-dependent mechanism. Biochem Biophys Res Commun 2010; 391: 1043–1048.

    Article  CAS  PubMed  Google Scholar 

  43. Li C, Liu Q, Li N, Chen W, Wang L, Wang Y et al. EAPF/Phafin-2, a novel endoplasmic reticulum-associated protein, facilitates TNF-alpha-triggered cellular apoptosis through endoplasmic reticulum-mitochondrial apoptotic pathway. J Mol Med (Berl) 2008; 86: 471–484.

    Article  CAS  Google Scholar 

  44. Stefansson B, Ohama T, Daugherty AE, Brautigan DL . Protein phosphatase 6 regulatory subunits composed of ankyrin repeat domains. Biochemistry 2008; 47: 1442–1451.

    Article  CAS  PubMed  Google Scholar 

  45. Chio A, Schymick JC, Restagno G, Scholz SW, Lombardo F, Lai SL et al. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 2009; 18: 1524–1532.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Kosoy R, Nassir R, Tian C, White PA, Butler LM, Silva G et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 2009; 30: 69–78.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Jabs WJ, Hennig C, Zawatzky R, Kirchner H . Failure to detect antiviral activity in serum and plasma of healthy individuals displaying high activity in ELISA for IFN-alpha and IFN-beta. J Interferon Cytokine Res 1999; 19: 463–469.

    Article  CAS  PubMed  Google Scholar 

  48. Hua J, Kirou K, Lee C, Crow MK . Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 2006; 54: 1906–1916.

    Article  CAS  PubMed  Google Scholar 

  49. Feng X, Han D, Kilaru BK, Franek BS, Niewold TB, Reder AT . Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins. Arch Neurol 2012; 69: 1303–1309.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Yeung KY, Ruzzo WL . Principal component analysis for clustering gene expression data. Bioinformatics 2001; 17: 763–774.

    Article  CAS  PubMed  Google Scholar 

  51. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Whitlock MC . Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J Evol Biol 2005; 18: 1368–1373.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Research reported in this publication was supported by the National Institutes of Health under award numbers: R01 AR060861 (NTB), UL1 RR024999 (NTB), K08 AI083790 (NTB), LRP AI071651 (NTB), N01 AR62277 (HJB), R3724717 (HJB), AR042460 (HJB), P01 AI083194 (HJB), P20 RR020143 (HJB), R01 DE018209 (HJB), R01 AR043274 (SKL), R01 CA141700 (ARME), RC1 AR058621 (ARME), RO1 AR43814 (TBP), P60 AR053308 (CLA), R01 AR44804 (CLA) and UL1 TR000004. Additional support was granted from the HHMI Gilliam Fellowship for Advanced Study (KSN), Alliance for Lupus Research (NTB, SKL, CLA and JCO), Merit Award from the US Department of Veterans Affairs (HJB), Lupus Research Institute (NTB), the Arthritis National Research Foundation Eng Tan Scholar Award (NTB), and the Lupus Foundation of Minnesota (NTB and SKL), Mayo Clinic Foundation (NTB), Kirkland Scholar Award (CLA) and the Wake Forest University Health Sciences Center for Public Health Genomics (LCD). We also thank the Instituto de Salud Carlos III (PI12/02558), partly supported with FEDER funds from the EU and the RNP Network BIOLUPUS financed by the European Science Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

Author information

Author notes

  1. S N Kariuki and Y Ghodke-Puranik: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Human Genetics, University of Chicago, Chicago, IL, USA

    S N Kariuki & A D Skol

  2. Department of Immunology and Division of Rheumatology, Mayo Clinic, Rochester, MN, USA

    Y Ghodke-Puranik, J M Dorschner & T B Niewold

  3. Gwen Knapp Center for Lupus Research, University of Chicago, Chicago, IL, USA

    B S Chrabot

  4. Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA

    J A Kelly, M E Alarcón-Riquelme & K L Sivils

  5. Department of Medicine, University of California, Los Angeles, CA, USA

    B P Tsao

  6. Department of Medicine, University of Alabama, Birmingham, AL, USA

    R P Kimberly

  7. GENYO Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain,

    M E Alarcón-Riquelme

  8. Department of Medicine, University of Southern California, Los Angeles, CA, USA

    C O Jacob

  9. Rosalind Russell/Ephraim P Engleman Rheumatology Research Center, University of California, San Francisco, CA, USA

    L A Criswell

  10. Department of Biostatistical Sciences, Wake Forest University, Winston-Salem, NC, USA

    C D Langefeld

  11. Cincinnati Children’s Hospital Medical Center and Cincinnati VA Medical Center, Cincinnati, OH, USA

    J B Harley

Authors
  1. S N Kariuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Ghodke-Puranik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J M Dorschner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B S Chrabot
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J A Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B P Tsao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R P Kimberly
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M E Alarcón-Riquelme
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C O Jacob
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. L A Criswell
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. K L Sivils
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. C D Langefeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. J B Harley
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. A D Skol
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. T B Niewold
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T B Niewold.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on Genes and Immunity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kariuki, S., Ghodke-Puranik, Y., Dorschner, J. et al. Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus. Genes Immun 16, 15–23 (2015). https://doi.org/10.1038/gene.2014.57

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gene.2014.57

This article is cited by

Search

Advanced search

Quick links